Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-04-27 | 2018-06-06 | 47338 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-11-23 | 2019-01-03 | 67490 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-02-21 | 2020-04-21 | 106958 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-03-31 | 2020-04-21 | 110235 |
| TOBREX | .3% | SOLUTION | Resolved | 2017-09-05 | 2017-09-14 | 20963 |
| TOBREX | .3% | SOLUTION | Resolved | 2018-12-11 | 2019-02-05 | 69257 |
| IZBA | 0.003% | SOLUTION | Resolved | 2022-04-11 | 2022-05-11 | 158479 |
| IZBA | 0.003% | SOLUTION | Resolved | 2022-09-29 | 2023-01-06 | 170482 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-01-08 | 2018-02-08 | 35254 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-03-16 | 2022-04-06 | 156780 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-05-04 | 2022-08-05 | 159990 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-04-18 | 2018-04-20 | 46280 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2019-08-13 | 2019-11-07 | 91488 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2022-01-12 | 2024-04-05 | 152583 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| LOPRESOR INJ 1.0MG/ML | 1MG | SOLUTION | Discontinued | 2019-04-05 | 2019-09-06 | 80607 |
| SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-07 | 128059 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-06 | 128062 |
| LOTENSIN 20MG | 20MG | TABLET | Discontinued | 2017-09-27 | 2018-08-29 | 23762 |
| RITALIN 20MG | 20MG | TABLET | Discontinued | 2019-07-22 | 2019-08-01 | 89771 |
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-02-08 | 2022-04-05 | 154439 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2019-03-20 | 35419 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35425 |